Pseudomonas aeruginosa cell surface structures

Pseudomonas aeruginosa cell surface structures comprise a complex assembly of macromolecules including lipopolysaccharides (LPS), type IV pili, flagella, and exopolysaccharides such as alginate, Psl, and Pel (Burrows, 2012, Annual Review of Microbiology). These structures are essential for the bacterium's environmental adaptation, enabling various forms of motility and the initial attachment to host epithelial cells during infection (King et al., 2009, Journal of Endotoxin Research). They play a pivotal role in the pathogenesis of healthcare-associated infections and chronic respiratory colonization in cystic fibrosis patients by facilitating biofilm formation, which protects the bacteria from both host immune responses and antibiotic penetration (Govan & Deretic, 1996, Microbiological Reviews). Therapeutic strategies often target these components; for example, polymyxin antibiotics interact directly with the Lipid A component of LPS to disrupt membrane stability (Nation et al., 2014, Clinical Infectious Diseases). Additionally, novel biologicals like the bispecific antibody MEDI3902 target surface proteins like PcrV and the Psl polysaccharide to enhance bacterial clearance (DiGiandomenico et al., 2014, Science Translational Medicine). Understanding the diversity and regulation of these surface structures is critical for developing effective vaccines and overcoming the challenges of multi-drug resistant Pseudomonas strains.

Other names

Pseudomonas aeruginosa surface antigensP. aeruginosa cell envelope componentsPseudomonas surface moleculesBacterial outer membrane structures

Drugs targeting these structures typically act by disrupting the integrity of the outer membrane (e.g., polymyxins binding to Lipid A), inhibiting protein synthesis via membrane penetration (e.g., aminoglycosides), or neutralizing specific virulence factors and adhesins through monoclonal antibody binding to prevent host cell attachment and facilitate opsonophagocytosis.